Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Nipro Diagnostics, Inc. · Predicate Candidate Screening

4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K150052TRUE METRIX AIR Self-Monitoring Blood Glucose System, TRUE MNipro Diagnostics, Inc.2015-03-26731
K140100TRUE METRIX SELF-MONITORING BLOOD GLUCOSE SYSTEM, TRUE METRINipro Diagnostics, Inc.2014-08-011983
K132072TRUE METRIX SELF-MONITORING BLOOD GLUCOSE SYSTEM, TRUE METRINipro Diagnostics, Inc.2013-08-15430
K120989TRUE METRIX SELF-MONITORING BLOOD GLUCOSE SYSTEM, TRUE METRINipro Diagnostics, Inc.2013-04-243870

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda